世界のがん生物毒素治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cancer Biological Toxins Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5640
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、がん生物毒素治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、免疫療法、標的療法）、用途別市場規模（病院、実験室、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・がん生物毒素治療薬の市場動向
・企業の競争状況、市場シェア
・がん生物毒素治療薬の種類別市場規模と予測2016-2027（ホルモン療法、免疫療法、標的療法）
・がん生物毒素治療薬の用途別市場規模と予測2016-2027（病院、実験室、その他）
・がん生物毒素治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・がん生物毒素治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・がん生物毒素治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・がん生物毒素治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・がん生物毒素治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen Inc.、AstraZeneca PLC、Bayer AG、Bristol-Myers Squibb Company、Celgene Corporation、Exelixis, Inc.、Merck、Pfizer Inc,、Sanofi）
・結論

Treatment of cancer disease depends on the stage of disease progression. Chemotherapy is widely used in earlier stages but there are other therapy options like immunological therapy and targeted drugs used in later stages.

Market Analysis and Insights: Global Cancer Biological Toxins Drug Market
The global Cancer Biological Toxins Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Biological Toxins Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Biological Toxins Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Biological Toxins Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Biological Toxins Drug market.

Global Cancer Biological Toxins Drug Scope and Market Size
Cancer Biological Toxins Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Biological Toxins Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hormonal Therapy
Immunotherapy
Targeted Therapy

Segment by Application
Hospital
Laboratory
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc.
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Exelixis, Inc.
Merck
Pfizer Inc,
Sanofi

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biological Toxins Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormonal Therapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.3 Market by Application
1.3.1 Global Cancer Biological Toxins Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer Biological Toxins Drug Market Perspective (2016-2027)
2.2 Cancer Biological Toxins Drug Growth Trends by Regions
2.2.1 Cancer Biological Toxins Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Biological Toxins Drug Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Biological Toxins Drug Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Biological Toxins Drug Industry Dynamic
2.3.1 Cancer Biological Toxins Drug Market Trends
2.3.2 Cancer Biological Toxins Drug Market Drivers
2.3.3 Cancer Biological Toxins Drug Market Challenges
2.3.4 Cancer Biological Toxins Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Biological Toxins Drug Players by Revenue
3.1.1 Global Top Cancer Biological Toxins Drug Players by Revenue (2016-2021)
3.1.2 Global Cancer Biological Toxins Drug Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Biological Toxins Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Biological Toxins Drug Revenue
3.4 Global Cancer Biological Toxins Drug Market Concentration Ratio
3.4.1 Global Cancer Biological Toxins Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biological Toxins Drug Revenue in 2020
3.5 Cancer Biological Toxins Drug Key Players Head office and Area Served
3.6 Key Players Cancer Biological Toxins Drug Product Solution and Service
3.7 Date of Enter into Cancer Biological Toxins Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Biological Toxins Drug Breakdown Data by Type
4.1 Global Cancer Biological Toxins Drug Historic Market Size by Type (2016-2021)
4.2 Global Cancer Biological Toxins Drug Forecasted Market Size by Type (2022-2027)

5 Cancer Biological Toxins Drug Breakdown Data by Application
5.1 Global Cancer Biological Toxins Drug Historic Market Size by Application (2016-2021)
5.2 Global Cancer Biological Toxins Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cancer Biological Toxins Drug Market Size (2016-2027)
6.2 North America Cancer Biological Toxins Drug Market Size by Type
6.2.1 North America Cancer Biological Toxins Drug Market Size by Type (2016-2021)
6.2.2 North America Cancer Biological Toxins Drug Market Size by Type (2022-2027)
6.2.3 North America Cancer Biological Toxins Drug Market Size by Type (2016-2027)
6.3 North America Cancer Biological Toxins Drug Market Size by Application
6.3.1 North America Cancer Biological Toxins Drug Market Size by Application (2016-2021)
6.3.2 North America Cancer Biological Toxins Drug Market Size by Application (2022-2027)
6.3.3 North America Cancer Biological Toxins Drug Market Size by Application (2016-2027)
6.4 North America Cancer Biological Toxins Drug Market Size by Country
6.4.1 North America Cancer Biological Toxins Drug Market Size by Country (2016-2021)
6.4.2 North America Cancer Biological Toxins Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cancer Biological Toxins Drug Market Size (2016-2027)
7.2 Europe Cancer Biological Toxins Drug Market Size by Type
7.2.1 Europe Cancer Biological Toxins Drug Market Size by Type (2016-2021)
7.2.2 Europe Cancer Biological Toxins Drug Market Size by Type (2022-2027)
7.2.3 Europe Cancer Biological Toxins Drug Market Size by Type (2016-2027)
7.3 Europe Cancer Biological Toxins Drug Market Size by Application
7.3.1 Europe Cancer Biological Toxins Drug Market Size by Application (2016-2021)
7.3.2 Europe Cancer Biological Toxins Drug Market Size by Application (2022-2027)
7.3.3 Europe Cancer Biological Toxins Drug Market Size by Application (2016-2027)
7.4 Europe Cancer Biological Toxins Drug Market Size by Country
7.4.1 Europe Cancer Biological Toxins Drug Market Size by Country (2016-2021)
7.4.2 Europe Cancer Biological Toxins Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cancer Biological Toxins Drug Market Size (2016-2027)
8.2 Asia-Pacific Cancer Biological Toxins Drug Market Size by Type
8.2.1 Asia-Pacific Cancer Biological Toxins Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Biological Toxins Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Biological Toxins Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Biological Toxins Drug Market Size by Application
8.3.1 Asia-Pacific Cancer Biological Toxins Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Biological Toxins Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Biological Toxins Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Biological Toxins Drug Market Size by Region
8.4.1 Asia-Pacific Cancer Biological Toxins Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Biological Toxins Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cancer Biological Toxins Drug Market Size (2016-2027)
9.2 Latin America Cancer Biological Toxins Drug Market Size by Type
9.2.1 Latin America Cancer Biological Toxins Drug Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Biological Toxins Drug Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Biological Toxins Drug Market Size by Type (2016-2027)
9.3 Latin America Cancer Biological Toxins Drug Market Size by Application
9.3.1 Latin America Cancer Biological Toxins Drug Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Biological Toxins Drug Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Biological Toxins Drug Market Size by Application (2016-2027)
9.4 Latin America Cancer Biological Toxins Drug Market Size by Country
9.4.1 Latin America Cancer Biological Toxins Drug Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Biological Toxins Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer Biological Toxins Drug Market Size (2016-2027)
10.2 Middle East & Africa Cancer Biological Toxins Drug Market Size by Type
10.2.1 Middle East & Africa Cancer Biological Toxins Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Biological Toxins Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Biological Toxins Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Biological Toxins Drug Market Size by Application
10.3.1 Middle East & Africa Cancer Biological Toxins Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Biological Toxins Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Biological Toxins Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Biological Toxins Drug Market Size by Country
10.4.1 Middle East & Africa Cancer Biological Toxins Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Biological Toxins Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Cancer Biological Toxins Drug Introduction
11.1.4 Amgen Inc. Revenue in Cancer Biological Toxins Drug Business (2016-2021)
11.1.5 Amgen Inc. Recent Development
11.2 AstraZeneca PLC
11.2.1 AstraZeneca PLC Company Details
11.2.2 AstraZeneca PLC Business Overview
11.2.3 AstraZeneca PLC Cancer Biological Toxins Drug Introduction
11.2.4 AstraZeneca PLC Revenue in Cancer Biological Toxins Drug Business (2016-2021)
11.2.5 AstraZeneca PLC Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Cancer Biological Toxins Drug Introduction
11.3.4 Bayer AG Revenue in Cancer Biological Toxins Drug Business (2016-2021)
11.3.5 Bayer AG Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Details
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Cancer Biological Toxins Drug Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Cancer Biological Toxins Drug Business (2016-2021)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Cancer Biological Toxins Drug Introduction
11.5.4 Celgene Corporation Revenue in Cancer Biological Toxins Drug Business (2016-2021)
11.5.5 Celgene Corporation Recent Development
11.6 Exelixis, Inc.
11.6.1 Exelixis, Inc. Company Details
11.6.2 Exelixis, Inc. Business Overview
11.6.3 Exelixis, Inc. Cancer Biological Toxins Drug Introduction
11.6.4 Exelixis, Inc. Revenue in Cancer Biological Toxins Drug Business (2016-2021)
11.6.5 Exelixis, Inc. Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Cancer Biological Toxins Drug Introduction
11.7.4 Merck Revenue in Cancer Biological Toxins Drug Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Pfizer Inc,
11.8.1 Pfizer Inc, Company Details
11.8.2 Pfizer Inc, Business Overview
11.8.3 Pfizer Inc, Cancer Biological Toxins Drug Introduction
11.8.4 Pfizer Inc, Revenue in Cancer Biological Toxins Drug Business (2016-2021)
11.8.5 Pfizer Inc, Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Cancer Biological Toxins Drug Introduction
11.9.4 Sanofi Revenue in Cancer Biological Toxins Drug Business (2016-2021)
11.9.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cancer Biological Toxins Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Global Cancer Biological Toxins Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cancer Biological Toxins Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Biological Toxins Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cancer Biological Toxins Drug Market Share by Regions (2016-2021)
Table 9. Global Cancer Biological Toxins Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cancer Biological Toxins Drug Market Share by Regions (2022-2027)
Table 11. Cancer Biological Toxins Drug Market Trends
Table 12. Cancer Biological Toxins Drug Market Drivers
Table 13. Cancer Biological Toxins Drug Market Challenges
Table 14. Cancer Biological Toxins Drug Market Restraints
Table 15. Global Cancer Biological Toxins Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cancer Biological Toxins Drug Market Share by Players (2016-2021)
Table 17. Global Top Cancer Biological Toxins Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biological Toxins Drug as of 2020)
Table 18. Ranking of Global Top Cancer Biological Toxins Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cancer Biological Toxins Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Biological Toxins Drug Product Solution and Service
Table 22. Date of Enter into Cancer Biological Toxins Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Biological Toxins Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cancer Biological Toxins Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Cancer Biological Toxins Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cancer Biological Toxins Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cancer Biological Toxins Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cancer Biological Toxins Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Cancer Biological Toxins Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cancer Biological Toxins Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cancer Biological Toxins Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cancer Biological Toxins Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cancer Biological Toxins Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cancer Biological Toxins Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cancer Biological Toxins Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cancer Biological Toxins Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cancer Biological Toxins Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cancer Biological Toxins Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cancer Biological Toxins Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cancer Biological Toxins Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cancer Biological Toxins Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cancer Biological Toxins Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cancer Biological Toxins Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cancer Biological Toxins Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cancer Biological Toxins Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cancer Biological Toxins Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cancer Biological Toxins Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cancer Biological Toxins Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cancer Biological Toxins Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cancer Biological Toxins Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cancer Biological Toxins Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cancer Biological Toxins Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cancer Biological Toxins Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cancer Biological Toxins Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cancer Biological Toxins Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cancer Biological Toxins Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cancer Biological Toxins Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cancer Biological Toxins Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cancer Biological Toxins Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cancer Biological Toxins Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Amgen Inc. Company Details
Table 63. Amgen Inc. Business Overview
Table 64. Amgen Inc. Cancer Biological Toxins Drug Product
Table 65. Amgen Inc. Revenue in Cancer Biological Toxins Drug Business (2016-2021) & (US$ Million)
Table 66. Amgen Inc. Recent Development
Table 67. AstraZeneca PLC Company Details
Table 68. AstraZeneca PLC Business Overview
Table 69. AstraZeneca PLC Cancer Biological Toxins Drug Product
Table 70. AstraZeneca PLC Revenue in Cancer Biological Toxins Drug Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca PLC Recent Development
Table 72. Bayer AG Company Details
Table 73. Bayer AG Business Overview
Table 74. Bayer AG Cancer Biological Toxins Drug Product
Table 75. Bayer AG Revenue in Cancer Biological Toxins Drug Business (2016-2021) & (US$ Million)
Table 76. Bayer AG Recent Development
Table 77. Bristol-Myers Squibb Company Company Details
Table 78. Bristol-Myers Squibb Company Business Overview
Table 79. Bristol-Myers Squibb Company Cancer Biological Toxins Drug Product
Table 80. Bristol-Myers Squibb Company Revenue in Cancer Biological Toxins Drug Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Company Recent Development
Table 82. Celgene Corporation Company Details
Table 83. Celgene Corporation Business Overview
Table 84. Celgene Corporation Cancer Biological Toxins Drug Product
Table 85. Celgene Corporation Revenue in Cancer Biological Toxins Drug Business (2016-2021) & (US$ Million)
Table 86. Celgene Corporation Recent Development
Table 87. Exelixis, Inc. Company Details
Table 88. Exelixis, Inc. Business Overview
Table 89. Exelixis, Inc. Cancer Biological Toxins Drug Product
Table 90. Exelixis, Inc. Revenue in Cancer Biological Toxins Drug Business (2016-2021) & (US$ Million)
Table 91. Exelixis, Inc. Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Cancer Biological Toxins Drug Product
Table 95. Merck Revenue in Cancer Biological Toxins Drug Business (2016-2021) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Pfizer Inc, Company Details
Table 98. Pfizer Inc, Business Overview
Table 99. Pfizer Inc, Revenue in Cancer Biological Toxins Drug Business (2016-2021) & (US$ Million)
Table 100. Pfizer Inc, Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Cancer Biological Toxins Drug Product
Table 104. Sanofi Revenue in Cancer Biological Toxins Drug Business (2016-2021) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Biological Toxins Drug Market Share by Type: 2020 VS 2027
Figure 2. Hormonal Therapy Features
Figure 3. Immunotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Global Cancer Biological Toxins Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Laboratory Case Studies
Figure 8. Others Case Studies
Figure 9. Cancer Biological Toxins Drug Report Years Considered
Figure 10. Global Cancer Biological Toxins Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cancer Biological Toxins Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cancer Biological Toxins Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Cancer Biological Toxins Drug Market Share by Regions (2022-2027)
Figure 14. Global Cancer Biological Toxins Drug Market Share by Players in 2020
Figure 15. Global Top Cancer Biological Toxins Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biological Toxins Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cancer Biological Toxins Drug Revenue in 2020
Figure 17. Global Cancer Biological Toxins Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Cancer Biological Toxins Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cancer Biological Toxins Drug Market Share by Type (2016-2027)
Figure 21. North America Cancer Biological Toxins Drug Market Share by Application (2016-2027)
Figure 22. North America Cancer Biological Toxins Drug Market Share by Country (2016-2027)
Figure 23. United States Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer Biological Toxins Drug Market Share by Type (2016-2027)
Figure 27. Europe Cancer Biological Toxins Drug Market Share by Application (2016-2027)
Figure 28. Europe Cancer Biological Toxins Drug Market Share by Country (2016-2027)
Figure 29. Germany Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer Biological Toxins Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cancer Biological Toxins Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cancer Biological Toxins Drug Market Share by Region (2016-2027)
Figure 39. China Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer Biological Toxins Drug Market Share by Type (2016-2027)
Figure 47. Latin America Cancer Biological Toxins Drug Market Share by Application (2016-2027)
Figure 48. Latin America Cancer Biological Toxins Drug Market Share by Country (2016-2027)
Figure 49. Mexico Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer Biological Toxins Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cancer Biological Toxins Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cancer Biological Toxins Drug Market Share by Country (2016-2027)
Figure 55. Turkey Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cancer Biological Toxins Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Amgen Inc. Revenue Growth Rate in Cancer Biological Toxins Drug Business (2016-2021)
Figure 59. AstraZeneca PLC Revenue Growth Rate in Cancer Biological Toxins Drug Business (2016-2021)
Figure 60. Bayer AG Revenue Growth Rate in Cancer Biological Toxins Drug Business (2016-2021)
Figure 61. Bristol-Myers Squibb Company Revenue Growth Rate in Cancer Biological Toxins Drug Business (2016-2021)
Figure 62. Celgene Corporation Revenue Growth Rate in Cancer Biological Toxins Drug Business (2016-2021)
Figure 63. Exelixis, Inc. Revenue Growth Rate in Cancer Biological Toxins Drug Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Cancer Biological Toxins Drug Business (2016-2021)
Figure 65. Pfizer Inc, Revenue Growth Rate in Cancer Biological Toxins Drug Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Cancer Biological Toxins Drug Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の乳がん診断＆薬物技術市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast 2021-2027
QFJ1-3938 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、乳がん診断＆薬物技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（マンモグラフィ、生検、その他）、用途別市場規模（乳管癌、浸潤性乳管癌、小葉癌、トリプルネガティブ乳がん）、主要地域別市場規模（北米、...

世界の小分子標的抗がん剤市場規模・現状・予測（2021年-2027年）

Global Small Molecule Targeted Anti-cancer Drug Market Size, Status and Forecast 2021-2027
QFJ1-6013 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、小分子標的抗がん剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（EGFR、ALK、Bcr-Abl、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地...

世界の癌におけるドラッグデリバリー市場規模・現状・予測（2021年-2027年）

Global Drug Delivery in Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4156 2021年6月 128Pages
QYResearch社発行の本調査レポートでは、癌におけるドラッグデリバリーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リポソーム、PEG化タンパク質＆ポリペプチド、ポリマーナノ粒子、タンパク質薬物複合体、その他）、用途別市場規模（病院＆診療所...

世界の膵臓＆胆管がん治療薬市場規模・現状・予測（2021年-2027年）

Global Pancreatic and Bile Duct Cancer Drug Market Size, Status and Forecast 2021-2027
QFJ1-5927 2021年6月 125Pages
QYResearch社発行の本調査レポートでは、膵臓＆胆管がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血管内皮増殖因子受容体、プログラム細胞死タンパク質1、転写シグナル伝達活性化因子3、その他）、用途別市場規模（膵臓がん、胆管がん）、...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の小分子標的薬市場規模・現状・予測（2021年-2027年）

Global Small Molecule Targted Drug Market Size, Status and Forecast 2021-2027
QFJ1-6014 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、小分子標的薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TKI、マルチターゲット阻害剤、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地域別市場...

世界の皮膚がん分子診断市場規模・現状・予測（2021年-2027年）

Global Skin Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4867 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、皮膚がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の精巣がん分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Testicular Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4522 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、精巣がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年）

Global Laryngeal Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4412 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、喉頭がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の小分子標的抗がん剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Anti-cancer Drug Market The global Small Molecule Targeted Anti-cancer Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の乳がん診断＆薬物技術市場規模・現状・予測（2021年-2027年） Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on. Market Analysis and Insights: Global Breast Cancer Diagnostic and Drug Technologies Market The global Breast Cancer Diagno…
世界の肺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapy Market The global Lung Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界のがん点滴療法市場規模・現状・予測（2021年-2027年） Cancer treatments often require infusion treatments, like chemotherapy. Market Analysis and Insights: Global Cancer Infusion Therapy Market The global Cancer Infusion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. Wi…
世界の癌におけるドラッグデリバリー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Delivery in Cancer Market The global Drug Delivery in Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…